Literature DB >> 18312767

Meta-analysis comparing reported frequency of atrial fibrillation after acute coronary syndromes in Asians versus whites.

Gian M Novaro1, Craig R Asher, Deepak L Bhatt, David J Moliterno, Robert A Harrington, A Michael Lincoff, L Kristin Newby, James E Tcheng, Amy P Hsu, Sergio L Pinski.   

Abstract

The development of atrial fibrillation (AF) in cardiac patients is multifactorial, including not well defined genetic factors. To determine if Asian ethnicity is associated with the development of AF in patients with coronary disease, a meta-analysis was conducted of patient-level data from 7 prospective randomized clinical trials that prospectively collected information on the development of AF: 3 trials in patients with ST-elevation myocardial infarction (Global Use of Strategies to Open Occluded Coronary Arteries [GUSTO] I, GUSTO III, and GUSTO V), 3 trials in patients with non-ST-elevation acute coronary syndromes (Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy [PURSUIT], Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis-II [IMPACT II], and Platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary Syndrome Events in a Global Organization Network [PARAGON A]), and 1 trial in patients with both conditions (GUSTO IIb). A total of 94,785 patients were identified (93,050 white, 1,735 Asian). At baseline, Asian patients were younger; had lower body mass indexes; had a lower prevalence of female gender, previous angioplasty, and previous coronary artery bypass grafting; and had a greater prevalence of diabetes compared with white patients. The development of AF was lower in Asian than in white patients (4.7% vs 7.6%, p <0.001), while rates of ventricular tachycardia and fibrillation were similar in the 2 groups. In multivariate logistic regression analysis, Asian ethnicity was associated with significantly lower rates of AF (odds ratio 0.65, 95% confidence interval 0.50 to 0.84, p = 0.001) compared with white ethnicity. In conclusion, similar to previous studies showing a lower incidence of AF in non-Caucasian populations, Asians experiencing acute ischemic syndromes have a significantly lower frequency of AF compared with whites. Further study is needed to investigate the mechanisms and potential genetic underpinnings behind this association.

Entities:  

Mesh:

Year:  2007        PMID: 18312767     DOI: 10.1016/j.amjcard.2007.09.098

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

Review 1.  Atrial Fibrillation Complicating Acute Coronary Syndromes.

Authors:  Sean D Pokorney; Meena Rao; Kent R Nilsson; Jonathan P Piccini
Journal:  J Atr Fibrillation       Date:  2012-10-06

Review 2.  Mechanisms of new-onset atrial fibrillation complicating acute coronary syndrome.

Authors:  J Wang; Y-M Yang; J Zhu
Journal:  Herz       Date:  2014-10-30       Impact factor: 1.443

3.  Ventricular Arrhythmia Risk Based on Ethnicity in COVID-19 Patients on Hydroxychloroquine and Azithromycin Combination: Viewpoint.

Authors:  Sayak Roy
Journal:  SN Compr Clin Med       Date:  2020-06-27

4.  Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop.

Authors:  Emelia J Benjamin; Peng-Sheng Chen; Diane E Bild; Alice M Mascette; Christine M Albert; Alvaro Alonso; Hugh Calkins; Stuart J Connolly; Anne B Curtis; Dawood Darbar; Patrick T Ellinor; Alan S Go; Nora F Goldschlager; Susan R Heckbert; José Jalife; Charles R Kerr; Daniel Levy; Donald M Lloyd-Jones; Barry M Massie; Stanley Nattel; Jeffrey E Olgin; Douglas L Packer; Sunny S Po; Teresa S M Tsang; David R Van Wagoner; Albert L Waldo; D George Wyse
Journal:  Circulation       Date:  2009-02-03       Impact factor: 29.690

Review 5.  Apixaban to prevent stroke in patients with atrial fibrillation: a review.

Authors:  Benjamin E Peterson; Sana M Al-Khatib; Christopher B Granger
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-07-31

Review 6.  Clinical strategies for selecting oral anticoagulants in patients with atrial fibrillation.

Authors:  Sean D Pokorney; Matthew W Sherwood; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2013-08       Impact factor: 2.300

Review 7.  Atrial Fibrillation in Middle Eastern Arabs and South Asians: Summary of Published Articles in the Arabian Gulf.

Authors:  Amar M Salam
Journal:  Heart Views       Date:  2019-11-14

8.  Outcomes in elderly Chinese patients with atrial fibrillation and coronary artery disease. A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry.

Authors:  Agnieszka Kotalczyk; Yutao Guo; Ameenathul M Fawzy; Yutang Wang; Gregory Y H Lip
Journal:  J Arrhythm       Date:  2022-05-31

Review 9.  Atrial fibrillation: a review of recent studies with a focus on those from the duke clinical research institute.

Authors:  Meena P Rao; Sean D Pokorney; Christopher B Granger
Journal:  Scientifica (Cairo)       Date:  2014-08-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.